Buscar
🇪🇸
MEM
O
RY
.COM
4.37.48
Invitado
Iniciar sesión
Página de inicio
0
0
0
0
0
Crear curso
Cursos
Último juego
Panel
Notificaciones
Clases
Carpetas
Exámenes
Exámenes personalizados
Ayuda
Marcador
Tienda
Premios
Amigos
Asignaturas
Modo oscuro
Identificador de usuario: 999999
Versión: 4.37.48
www.memory.es
Estás en modo de exploración. debe iniciar sesión para usar
MEM
O
RY
Inicia sesión para empezar
Index
»
PHARMACOLOGY 1
»
Chapter 1
»
Level 2
level: Level 2
Questions and Answers List
THE NATURE OF DRUGS General Principles of Pharmacology
level questions: Level 2
Question
Answer
Routes of Administration
• buccal, sublingual, translingual • gastric • intradermal • intramuscular • intravenous • oral • rectal and vaginal • respiratory • subcutaneous • topical
Any substance that brings about a change in biologic function through its chemical actions
DRUG
1 activator -has affinity to the receptor and intrinsic activity 2 Inhibitor -has affinity only
1 AGONIST 2 ANTAGONIST
specific molecule in the biologic system that plays a regulatory role and where the drug molecule interacts
RECEPTOR
may interact directly with other drugs
Chemical Antagonists
from Greek "xenos," meaning stranger not synthesized in the body
XENOBIOTICS
Drugs that have almost exclusively harmful effects
POISONS
Poisons of biologic origin (ie. synthesized by plants and animals, in contrast to inorganic poisons such as lead and arsenic)
TOXINS
The Physical Nature of Drugs
• Solid - Aspirin, Atropine • Liquid - Nicotine, Ethanol • Gaseous - Nitrous Oxide
Drug Size, SMALLEST and LARGEST
1 Smallest -- Lithium ion (MW 7) 2 Largest -- Alteplase (MW 59,050) 3 Most drugs -- MW 100-1000
Three major types of bonds
1 covalent, 2 electrostatic and 3 hydrophobic
very strong bond and in many cases not reversible under biologic conditions EX. Aspirin with cyclooxygenase enzyme; DNA-alkylating agents used in cancer chemotherapy
COVALENT BONDS
vary from relatively strong linkages between permanently charged ionic molecules to weaker hydrogen bonds and very weak induced dipole interactions such as van der Waals forces WEAKER THAN COVALENT BONDS
Electrostatic Bonding
usually quite weak and are probably important in the interactions of highly lipid-soluble drugs with the lipids of cell membranes and perhaps in the interaction of drugs with the internal walls of receptor "pockets"
HYDROPHOBIC BONDS
dependent on the chirality (stereoisomerism) of the drug chemical structure
DRUG SHAPE
implies the ability to predict the appropriate molecular structure of a drug on the basis of information about its biologic receptor
Rational Drug Design
must undergo extensive animal studies
IND - Investigational New Drug